Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon

Gastroenterology

Volumn 151, Issue 5, 2016, Pages 933-944.e3

  Spohn, Stephanie N ^a   Bianco, Francesca ^c   Scott, Rachel B ^d   Keenan, Catherine M ^e,f   Linton, Alisha A ^a   O'Neill, Conor H ^a   Bonora, Elena ^c   Dicay, Michael ^f   Lavoie, Brigitte ^a   Wilcox, Rebecca L ^b   MacNaughton, Wallace K ^f   De Giorgio, Roberto ^c   Sharkey, Keith A ^e,f   Mawe, Gary M ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d DANBURY HOSPITAL   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colonic Motility; IBD; Mucosal Drug Action; Wound Healing

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; ENEMA; SEROTONIN 4 RECEPTOR; TEGASEROD; DEXTRAN SULFATE; INDOLE DERIVATIVE; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SULFONAMIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL TRANSLOCATION; CACO 2 CELL LINE; CELL MIGRATION; CELL PROLIFERATION; COLON MOTILITY; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; GUINEA PIG; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINAL TISSUE; INTESTINE MUCOSA PERMEABILITY; KNOCKOUT MOUSE; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; SPLEEN; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS; WILD TYPE MOUSE; WOUND HEALING; ANIMAL; CHEMICALLY INDUCED; COLITIS; COLON; DRUG EFFECTS; FEMALE; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; RECTAL DRUG ADMINISTRATION; SEVERITY OF ILLNESS INDEX;

ADMINISTRATION, RECTAL; ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; GUINEA PIGS; INDOLES; INTESTINAL MUCOSA; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN 5-HT4 RECEPTOR AGONISTS; SEROTONIN 5-HT4 RECEPTOR ANTAGONISTS; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TRINITROBENZENESULFONIC ACID;

EID: 84994853548     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.07.032     Document Type: Article

References (50)

1. 1 Berger, M., Gray, J.A., Roth, B.L., The expanded biology of serotonin. Annu Rev Med 60 (2009), 355–366.
2. 2 Mawe, G.M., Hoffman, J.M., Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10 (2013), 473–486.
3. 3 Liu, M.T., Kuan, Y.H., Wang, J., et al. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29 (2009), 9683–9699.
4. 4 Li, N., Ghia, J.E., Wang, H., et al. Serotonin activates dendritic cell function in the context of gut inflammation. Am J Pathol 178 (2011), 662–671.
5. 5 Kim, J.J., Bridle, B.W., Ghia, J.E., et al. Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J Immunol 190 (2013), 4795–4804.
6. 6 Pan, H., Galligan, J.J., 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 266 (1994), G230–G238.
7. 7 Tonini, M., Galligan, J.J., North, R.A., Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 96 (1989), 1257–1264.
8. 8 Hoffman, J.M., Tyler, K., MacEachern, S.J., et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 142 (2012), 844–854 e4.
9. 9 Fujisawa, M., Murata, T., Hori, M., et al. The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage. J Gastroenterol 45 (2010), 179–186.
10. 10 Takaki, M., Goto, K., Kawahara, I., The 5-hydroxytryptamine 4 receptor agonist-induced actions and enteric neurogenesis in the gut. J Neurogastroenterol Motil 20 (2014), 17–30.
11. 11 Cooper, H.S., Murthy, S.N., Shah, R.S., et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69 (1993), 238–249.
12. 12 Villanacci, V., Antonelli, E., Geboes, K., et al. Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J Gastroenterol 19 (2013), 968–978.
13. 13 Savidge, T.C., Newman, P., Pothoulakis, C., et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 132 (2007), 1344–1358.
14. 14 Joly, F., Mayeur, C., Messing, B., et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 297 (2009), G116–G123.
15. 15 Hoffman, J.M., Brooks, E.M., Mawe, G.M., Gastrointestinal motility monitor (GIMM). J Vis Exp, 46, 2010, 2435.
16. 16 Nasser, Y., Fernandez, E., Keenan, C.M., et al. Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function. Am J Physiol Gastrointest Liver Physiol 291 (2006), G912–G927.
17. 17 Roberts, J.A., Durnin, L., Sharkey, K.A., et al. Oxidative stress disrupts purinergic neuromuscular transmission in the inflamed colon. J Physiol 591 (2013), 3725–3737.
18. 18 Strong, D.S., Cornbrooks, C.F., Roberts, J.A., et al. Purinergic neuromuscular transmission is selectively attenuated in ulcerated regions of inflamed guinea pig distal colon. J Physiol 588 (2010), 847–859.
19. 19 Clement, M.V., Ponton, A., Pervaiz, S., Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 440 (1998), 13–18.
20. 20 Vichai, V., Kirtikara, K., Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1 (2006), 1112–1116.
21. 21 Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9 (2012), 671–675.
22. 22 MacEachern, S.J., Patel, B.A., Keenan, C.M., et al. Inhibiting inducible nitric oxide synthase in enteric glia restores electrogenic ion transport in mice with colitis. Gastroenterology 149 (2015), 445–455 e3.
23. 23 Heath, J.P., Epithelial cell migration in the intestine. Cell Biol Int 20 (1996), 139–146.
24. 24 Denker, S.P., Barber, D.L., Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J Cell Biol 159 (2002), 1087–1096.
25. 25 Shi, X.Z., Winston, J.H., Sarna, S.K., Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 300 (2011), G41–G51.
26. 26 Novak, E.A., Mollen, K.P., Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol, 3, 2015, 62.
27. 27 Becker, C., Watson, A.J., Neurath, M.F., Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144 (2013), 283–293.
28. 28 Reddy, S.N., Bazzocchi, G., Chan, S., et al. Colonic motility and transit in health and ulcerative colitis. Gastroenterology 101 (1991), 1289–1297.
29. 29 Brierley, S.M., Linden, D.R., Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat Rev Gastroenterol Hepatol 11 (2014), 611–627.
30. 30 Linden, D.R., Sharkey, K.A., Ho, W., et al. Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J Physiol 557 (2004), 191–205.
31. 31 Hoffman, J.M., McKnight, N.D., Sharkey, K.A., et al. The relationship between inflammation-induced neuronal excitability and disrupted motor activity in the guinea pig distal colon. Neurogastroenterol Motil, 23, 2011 673-e279.
32. 32 Linden, D.R., Sharkey, K.A., Mawe, G.M., Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J Physiol 547 (2003), 589–601.
33. 33 Deitch, E.A., Kemper, A.C., Specian, R.D., et al. A study of the relationship among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 32 (1992), 141–147.
34. 34 Gershon, M.D., Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc 123 (2012), 268–280.
35. 35 Ghia, J.E., Li, N., Wang, H., et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137 (2009), 1649–1660.
36. 36 Bischoff, S.C., Mailer, R., Pabst, O., et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 296 (2009), G685–G695.
37. 37 Matsuyoshi, H., Kuniyasu, H., Okumura, M., et al. A 5-HT(4)-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult. Neurogastroenterol Motil 22 (2010), 806–813 e226.
38. 38 Kawahara, I., Kuniyasu, H., Matsuyoshi, H., et al. Comparison of effects of a selective 5-HT reuptake inhibitor versus a 5-HT4 receptor agonist on in vivo neurogenesis at the rectal anastomosis in rats. Am J Physiol Gastrointest Liver Physiol 302 (2012), G588–G597.
39. 39 Belkind-Gerson, J., Hotta, R., Nagy, N., et al. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm Bowel Dis 21 (2015), 870–878.
40. 40 Van der Sluis, M., De Koning, B.A., De Bruijn, A.C., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006), 117–129.
41. 41 Johansson, M.E., Gustafsson, J.K., Holmen-Larsson, J., et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63 (2014), 281–291.
42. 42 Costa, M., Furness, J.B., The peristaltic reflex: an analysis of the nerve pathways and their pharmacology. Naunyn Schmiedebergs Arch Pharmacol 294 (1976), 47–60.
43. 43 D'Antona, G., Hennig, G.W., Costa, M., et al. Analysis of motor patterns in the isolated guinea-pig large intestine by spatio-temporal maps. Neurogastroenterol Motil 13 (2001), 483–492.
44. 44 Linden, D.R., Chen, J.X., Gershon, M.D., et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285 (2003), G207–G216.
45. 45 Bertrand, P.P., Real-time detection of serotonin release from enterochromaffin cells of the guinea-pig ileum. Neurogastroenterol Motil 16 (2004), 511–514.
46. 46 Patel, B.A., Bian, X., Quaiserova-Mocko, V., et al. In vitro continuous amperometric monitoring of 5-hydroxytryptamine release from enterochromaffin cells of the guinea pig ileum. Analyst 132 (2007), 41–47.
47. 47 Claeysen, S., Sebben, M., Becamel, C., et al. Constitutively active mutants of 5-HT4 receptors are they in unique active states?. EMBO Rep 2 (2001), 61–67.
48. 48 Blondel, O., Gastineau, M., Langlois, M., et al. The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor. Br J Pharmacol 125 (1998), 595–597.
49. 49 Claeysen, S., Sebben, M., Becamel, C., et al. Pharmacological properties of 5-hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors. Mol Pharmacol 58 (2000), 136–144.
50. 50 Kamel, R., Eftekhari, P., Garcia, S., et al. A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT4) receptor. Biochem Pharmacol 70 (2005), 1009–1018.